| Literature DB >> 35328254 |
Benedikt Hoeh1,2, Mike Wenzel1, Matthias Müller1, Clarissa Wittler1, Eva Schlenke1, Jan L Hohenhorst2,3, Jens Köllermann4, Thomas Steuber3, Markus Graefen3, Derya Tilki3,5,6, Simon Bernatz7, Pierre I Karakiewicz2, Felix Preisser1, Andreas Becker1, Luis A Kluth1, Philipp Mandel1, Felix K H Chun1.
Abstract
BACKGROUND: To test the impact of urethral sphincter length (USL) and anatomic variants of prostatic apex (Lee-type classification) in preoperative multiparametric magnet resonance imaging (mpMRI) on mid-term continence in prostate cancer patients treated with radical prostatectomy (RP).Entities:
Keywords: Lee-type; apex; functional outcome; membranous urethra; mid-term urinary continence; prostate cancer; radical prostatectomy
Year: 2022 PMID: 35328254 PMCID: PMC8947169 DOI: 10.3390/diagnostics12030701
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418
Figure 1Urethral sphincter length measurements in (A) sagittal and (B) coronal dimensions in a multiparametric MRI prior to radical prostatectomy.
Patient and clinicopathological characteristics of 86 radical prostatectomy patients between 03/2018 and 12/2019, stratified according to surgical approach (robotic-assisted vs. open); all values are median (IQR) or frequencies (%).
| Overall, | Robotic-Assisted RP, | Open RP, | ||
|---|---|---|---|---|
|
Length of urethral sphincter, coronal, in mm | 14.7 (13.0, 16.7) | 15.0 (13.7, 17.1) | 14.5 (12.2, 16.2) | 0.2 |
|
Length of urethral sphincter, sagital, in mm | 15.1 (12.8, 16.8) | 15.1 (14.1, 17.0) | 15.3 (10.8, 16.7) | 0.4 |
|
Length of urethral sphincter, axial, in mm | 10.2 (9.2, 11.2) | 9.9 (9.2, 11.1) | 10.2 (9.1, 11.2) | 0.8 |
|
Diameter of urethral sphincter, coronal, in mm | 9.1 (7.9, 10.1) | 9.4 (8.2, 10.1) | 8.7 (7.6, 9.8) | 0.2 |
|
Lee-type, | 0.3 | |||
| A | 11 (16%) | 5 (14%) | 6 (19%) | |
| B | 5 (7%) | 1 (3%) | 4 (13%) | |
| C | 5 (7%) | 4 (11%) | 1 (3%) | |
| D | 47 (69%) | 27 (73%) | 20 (65%) | |
|
Age in years, | 66 (58, 72) | 66 (58, 70) | 66 (60, 72) | 0.6 |
|
PSA, in ng/mL, | 7 (5, 10) | 6 (5, 8) | 8 (6, 15) | 0.005 |
|
Body-Mass Index in kg/m2, | 25.6 (24.0, 27.2) | 25.7 (23.9, 27.1) | 25.4 (24.2, 27.7) | 0.6 |
|
Prostate volume in mL, | 35 (28, 45) | 35 (29, 44) | 36 (28, 49) | 0.7 |
|
D’Amico Score, | <0.001 | |||
| Low | 5 (8%) | 4 (11%) | 1 (3%) | |
| Intermediate | 39 (59%) | 28 (78%) | 11 (37%) | |
| High | 22 (33%) | 4 (11%) | 18 (60%) | |
|
ISUP Score at biopsy, | <0.001 | |||
| ISUP1 | 7 (10%) | 4 (11%) | 3 (10%) | |
| ISUP2 | 26 (38%) | 21 (57%) | 5 (16%) | |
| ISUP3 | 17 (25%) | 8 (22%) | 9 (29%) | |
| ISUP4 | 10 (15%) | 4 (11%) | 6 (19%) | |
| ISUP5 | 8 (12%) | 0 (0%) | 8 (26%) | |
|
Pathological ISUP Score, | <0.001 | |||
| ISUP1 | 8 (12%) | 7 (19%) | 1 (3%) | |
| ISUP2 | 30 (46%) | 23 (62%) | 7 (26%) | |
| ISUP3 | 14 (22%) | 5 (14%) | 9 (32%) | |
| ISUP4 | 2 (3%) | 0 (0%) | 2 (7%) | |
| ISUP5 | 11 (17%) | 2 (5%) | 9 (32%) | |
|
Nerve sparing approach, | 0.003 | |||
| None | 6 (9%) | 0 (0%) | 6 (19%) | |
| Yes | 62 (91%) | 37 (100%) | 25 (81%) | |
|
pT-stage, | 0.02 | |||
| pT2 | 41 (60%) | 27 (73%) | 14 (45%) | |
| >pT2 | 27 (40%) | 10 (27%) | 17 (55%) | |
|
pN-stage, | 0.2 | |||
| pN0 | 60 (88%) | 34 (92%) | 26 (84%) | |
| pN1 | 3 (4%) | 0 (0%) | 3 (10%) | |
| pNx | 5 (8%) | 3 (8%) | 2 (6%) |
Abbreviations: IQR = interquartile range; RP = radical prostatectomy; ISUP = International Society of Urological Pathology; PSA = prostate-specific antigen.
Patient and clinicopathological characteristics of 86 radical prostatectomy patients between 03/2018 and 12/2019, stratified according to mid-term urinary continence status; all values are median (IQR) or frequencies (%).
| Overall, | Continent, | Incontinent, | ||
|---|---|---|---|---|
|
Length of urethral sphincter, coronal, in mm | 14.7 (13.0, 16.7) | 15.1 (13.8, 16.9) | 12.5 (11.9, 14.2) | 0.009 |
|
Length of urethral sphincter, sagital, in mm | 15.1 (12.8, 16.8) | 15.4 (14.4, 17.4) | 11.1 (9.8, 13.7) | <0.001 |
|
Length of urethral sphincter, axial, in mm | 10.2 (9.2, 11.2) | 9.7 (9.1, 11.2) | 10.5 (10.1, 11.1) | 0.5 |
|
Diameter of urethral sphincter, coronal, in mm | 9.1 (7.9, 10.1) | 9.1 (7.9, 10.1) | 9.4 (8.9, 9.9) | 0.5 |
|
Lee-type, | 0.4 | |||
| A | 11 (16%) | 8 (15%) | 3 (23%) | |
| B | 5 (7%) | 3 (6%) | 2 (15%) | |
| C | 5 (7%) | 4 (8%) | 1 (7.7%) | |
| D | 47 (69%) | 40 (73%) | 7 (54%) | |
|
Age in years, | 66 (58, 72) | 64 (58, 69) | 72 (68, 74) | 0.006 |
|
PSA, in ng/mL, | 7 (5, 10) | 7 (5, 10) | 7 (6, 11) | 0.7 |
|
Body-Mass Index, | 25.6 (24.0, 27.2) | 25.8 (24.0, 27.4) | 24.6 (24.1, 27.1) | 0.5 |
|
Prostate volume, in mL | 35 (28, 45) | 35 (26, 45) | 39 (30, 55) | 0.5 |
| D’Amico Score, n (%) | 0.030 | |||
| Low | 5 (8%) | 5 (9%) | 0 (0%) | |
| Intermediate | 39 (59%) | 35 (65%) | 4 (33%) | |
| High | 22 (33%) | 14 (26%) | 8 (67%) | |
|
ISUP Score at biopsy, | 0.08 | |||
| ISUP1 | 7 (10%) | 6 (11%) | 1 (8%) | |
| ISUP2 | 26 (38%) | 24 (44%) | 2 (15%) | |
| ISUP3 | 17 (25%) | 14 (25%) | 3 (23%) | |
| ISUP4 | 10 (15%) | 7 (12%) | 3 (23%) | |
| ISUP5 | 8 (12%) | 4 (8%) | 4 (31%) | |
| Pathological ISUP Score, n (%) | 0.008 | |||
| ISUP1 | 8 (12%) | 6 (11%) | 2 (18%) | |
| ISUP2 | 30 (46%) | 27 (50%) | 3 (27%) | |
| ISUP3 | 14 (22%) | 14 (26%) | 0 (0%) | |
| ISUP4 | 2 (3%) | 1 (2%) | 1 (9.1%) | |
| ISUP5 | 11 (17%) | 6 (11%) | 5 (45%) | |
| Nerve sparing approach, n (%) | 0.019 | |||
| None | 6 (9%) | 2 (4%) | 4 (31%) | |
| Yes | 62 (91%) | 53 (96%) | 9 (31%) | |
| pT-stage, n (%) | 0.2 | |||
| pT2 | 41 (60%) | 35 (64%) | 6 (46%) | |
| >pT2 | 27 (40%) | 20 (36%) | 7 (54%) | |
|
pN-stage, | 0.2 | |||
| pN0 | 60 (88%) | 50 (91%) | 10 (77%) | |
| pN1 | 3 (4%) | 2 (4%) | 1 (8%) | |
| pNx | 5 (8%) | 3 (6%) | 2 (15%) | |
| Surgical approach, n (%) | 0.012 | |||
| Robotic-assisted | 37 (54%) | 34 (62%) | 3 (23%) | |
| Open | 31 (46%) | 21 (38%) | 10 (77%) |
Abbreviations: IQR = interquartile range; RP = radical prostatectomy; ISUP = International Society of Urological Pathology; PSA = prostate-specific antigen.
Univariable and multivariable logistic regression models predicting urinary continence at medium follow-up following radical prostatectomy, defined as none or one safety pad per 24 h.
| Univariable | Multivariable | |||||||
|---|---|---|---|---|---|---|---|---|
| Odds Ratio | CI 2.5 % | CI 97.5 % | Odds Ratio | CI 2.5 % | CI 97.5 % | |||
| Urethral sphincter length, coronal | 1.42 | 1.09 | 1.96 | 0.02 | - | - | - | - |
| Urethral sphincter length, sagital | 1.69 | 1.31 | 2.33 | >0.001 | 1.67 | 1.22 | 2.52 | 0.005 |
| Urethral sphincter length, axial | 0.94 | 0.62 | 1.43 | 0.77 | - | - | - | - |
| Diameter of urethral sphincter, coronal | 0.88 | 0.57 | 1.33 | 0.54 | - | - | - | - |
| Lee-type | ||||||||
| A |
| - | - | - | - | |||
| B | 0.56 | 0.06 | 5.91 | 0.61 | - | - | - | - |
| C | 1.50 | 0.13 | 35.90 | 0.76 | - | - | - | - |
| D | 2.14 | 0.40 | 9.72 | 0.34 | - | - | - | - |
| Age | 0.88 | 0.79 | 0.97 | 0.02 | 0.87 | 0.73 | 0.99 | 0.04 |
| Prostate volume | 0.99 | 0.95 | 1.03 | 0.63 | - | - | - | - |
| pT-stage | ||||||||
| pT2 |
| - | - | - | - | |||
| >pT2 | 0.49 | 0.14 | 1.67 | 0.25 | - | - | - | - |
| Surgical approach | ||||||||
| Open RP |
| |||||||
| Robotic-assisted RP | 5.40 | 1.46 | 26.17 | 0.02 | 3.03 | 0.38 | 34.13 | 0.31 |
| Nerve sparing approach | ||||||||
| None |
| |||||||
| Yes | 11.78 | 2.01 | 94.71 | 0.01 | 0.79 | 0.01 | 45.67 | 0.90 |
| Pathological ISUP | ||||||||
| 1/2/3 |
| Ref. | ||||||
| 4/5 | 0.12 | 0.03 | 0.51 | 0.004 | 0.18 | 0.02 | 1.92 | 0.15 |
Abbreviations: RP = radical prostatectomy; CI = confidence interval; ISUP = International Society of Urological Pathology.
Univariable and multivariable logistic regression models predicting urinary continence at medium follow-up following radical prostatectomy, defined as none or one safety pad per 24 h.
| Univariable | Multivariable | |||||||
|---|---|---|---|---|---|---|---|---|
| Odds Ratio | CI 2.5 % | CI 97.5 % | Odds Ratio | CI 2.5 % | CI 97.5 % | |||
| Urethral sphincter length, coronal | 1.42 | 1.09 | 1.96 | 0.02 | 1.35 | 1.01 | 1.96 | 0.045 |
| Urethral sphincter length, sagital | 1.69 | 1.31 | 2.33 | >0.001 | - | - | - | - |
| Urethral sphincter length, axial | 0.94 | 0.62 | 1.43 | 0.77 | - | - | - | - |
| Diameter of urethral sphincter, coronal | 0.88 | 0.57 | 1.33 | 0.54 | - | - | - | - |
| Lee-type | ||||||||
| A |
| - | - | - | - | |||
| B | 0.56 | 0.06 | 5.91 | 0.61 | - | - | - | - |
| C | 1.50 | 0.13 | 35.90 | 0.76 | - | - | - | - |
| D | 2.14 | 0.40 | 9.72 | 0.34 | - | - | - | - |
| Age | 0.88 | 0.79 | 0.97 | 0.02 | 0.87 | 0.75 | 0.98 | 0.04 |
| Prostate volume | 0.99 | 0.95 | 1.03 | 0.63 | - | - | - | - |
| pT-stage | ||||||||
| pT2 |
| - | - | - | - | |||
| >pT2 | 0.49 | 0.14 | 1.67 | 0.25 | - | - | - | - |
| Surgical approach | ||||||||
| Open RP |
| |||||||
| Robotic-assisted RP | 5.40 | 1.46 | 26.17 | 0.02 | 2.35 | 0.36 | 18.01 | 0.37 |
| Nerve sparing approach | ||||||||
| None |
| |||||||
| Yes | 11.78 | 2.01 | 94.71 | 0.01 | 0.65 | 0.03 | 22.08 | 0.79 |
| Pathological ISUP | ||||||||
| 1/2/3 |
|
| ||||||
| 4/5 | 0.12 | 0.03 | 0.51 | 0.004 | 0.22 | 0.02 | 1.83 | 0.16 |
Abbreviations: RP = radical prostatectomy; CI = confidence interval; ISUP = International Society of Urological Pathology.